Synthesis and pharmacology of some new 2-arylamino-4-oxo[1,3]thiazino[5,6-b]quinoxalines was written by Bansal, O. P.;Srinivas, J. S.;Singh, P. P.;Junnarkar, A. Y.. And the article was included in Indian Journal of Chemistry in 1993.Recommanded Product: Ethyl 3-chloroquinoxaline-2-carboxylate This article mentions the following:
Several new 2-arylamino-4-oxo[1,3]thiazino[5,6-b]quinoxalines I (R = Ph, substituted phenyl) were prepared by treating Et 2-chloroquinoxaline-3-carboxylate with various arylthioureas. The compounds possess CNS depressant activity. In the experiment, the researchers used many compounds, for example, Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0Recommanded Product: Ethyl 3-chloroquinoxaline-2-carboxylate).
Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including as well as for RNA synthesis inhibition, reactive dyes and pigments, azo dyes, flurox Cylin Dyes, Corrosion Inhibitors and Photovoltaic Polymers. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Recommanded Product: Ethyl 3-chloroquinoxaline-2-carboxylate
Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider